Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

False · Brier 0.25

Rules 1.1.0 · as of 14 Sep 2026

Quote

“Were this to be addressed as a HIPAA issue, it might be an extinction level event.”
· SXSW Dispatch: BetterHelp Is a Disaster, Will It Destroy Teladoc? · substack post

After arguing the FTC-described data sharing was deliberate use of protected health information for financial gain, the author says that if it were treated as a HIPAA matter (HHS/DOJ) rather than an FTC trade matter, it might be an extinction-level event for the company (BetterHelp and parent Teladoc).

Intake

EventA proposition written from a template on the asset, with a resolution criterion and a named public source, before the outcome is looked up. The same event resolves every person's items on it. Method ›
BetterHelp or Teladoc Health ceases operations
AreaOne of five topic classes: regulatory decisions, clinical trial outcomes, company and market outcomes, payer and policy, practice adoption. Every event has one area. Method ›
Company and market outcomes
DeadlineThe date by which the event must happen for the item to be true. It comes only from the person's words through the anchor table. Method ›
None stated · undated panelItems with no deadline in the person's words, scored on a uniform 24-month window from the statement date. Part of the headline panel since rules 1.1.0; also shown on its own. Method ›, 24-month window to 12 Mar 2025
Probability
0.50 LexiconThe fixed five-bin table that turns a phrase into a probability. The strongest phrase in the claim sentence decides; coders never read tone. Method › · binOne of five lexicon steps: A 'will' 0.90, B 'probably' 0.70, C 'may' 0.50, D 'unlikely' 0.30, E 'never' 0.10. A stated number goes to the nearest bin for calibration only. Method › C · “might be an extinction level event”
Base rateThe probability a published external study gives an event of that class and stage, fixed at intake. Halved when the item window is shorter than the class median time to decision. Never learned from the ledger's own items. Method ›
None in the table
Tags
retrospective, conditional
Coder BCohen's kappa: agreement between two coders beyond chance, from -1 to 1. Reported for admit, event, deadline, bin and asserts from the second-coder match test. Method ›
admittedA statement that passed intake: sincere, the person's own claim, forward-looking, inside the five areas, and not excluded by a reason code. Only admitted statements become items. Method › · event E-0011 · deadline none · bin C
Registry entry

BetterHelp or its parent Teladoc Health ceases operations (shuts down, files for bankruptcy or is dissolved).

TRUE on the date of the definitive public announcement (SEC filing, press release or court filing) that BetterHelp ceases operations, or that Teladoc Health files for bankruptcy or is dissolved. A fine, a settlement, a stock decline, a write-down or a sale of BetterHelp as a going concern does not count. Resolution source: SEC EDGAR filings of Teladoc Health, with the company press release or bankruptcy docket as a secondary source. FALSE at the deadline when BetterHelp still operates and Teladoc Health has not filed for bankruptcy or been dissolved.

Resolution source: SEC EDGAR (Teladoc Health filings); company press release or bankruptcy docket as a secondary source

Readings: 'extinction level event' = BetterHelp ceases operations, or Teladoc Health files for bankruptcy or is dissolved. Fines, settlements, write-downs and stock declines do not count.; 'the company' = BetterHelp and its parent Teladoc Health, per the post context and title ('Will It Destroy Teladoc?'). Either counts: 'A or B' is one event.

How to read
The event, criterion and deadline were written at intake, before the outcome1 if the registry event happened on or before the item's deadline, 0 if it did not. Written by a resolver who never sees p. Method › was looked up. Coder B coded the statement independently.

Coder A

Resolution

State
False
Effective deadlineAn item enters the score only when its deadline has passed and the outcome is true or false. A claim already known true still waits for its deadline. Method ›
12 Mar 2025
Outcome1 if the registry event happened on or before the item's deadline, 0 if it did not. Written by a resolver who never sees p. Method ›
not occurred · checked through 13 Sep 2026
Resolver note
Criterion: a definitive SEC filing, press release or court filing that BetterHelp ceases operations, or that Teladoc Health files for bankruptcy or is dissolved. Checked 2026-09-13: EDGAR shows Teladoc Health (NYSE: TDOC) filing normally through 2026-09-11 (Forms 3, 4 and 144, and the 8-K of 2026-07-29), with no Item 1.03 bankruptcy 8-K, Form 15 or dissolution notice. The Q2 2026 results exhibit reports BetterHelp segment revenue of $212.6M (down 12%) and full-year 2026 BetterHelp guidance of $770-830M, so the platform is operating. Guidance cuts, a securities-law investigation and stock declines do not count. No shutdown or sale of BetterHelp was found in news through 2026-09-13. This states the position as of today only.
BrierThe squared gap between a probability and the outcome, (p - o)^2. 0 is perfect, 0.25 is the constant coin flip, 1 is confidently wrong. Lower is better. Method ›
0.25 = (0.50 − 0)²
How to read
State at window close; the outcome comes from the registry, the score from the rule.

Registry

Timeline

1 claim against 51 events in the field.

saiddueevent
16 Mar 2023 · Ketamine Wellness Centers (Delic Holdings): Ketamine Wellness Centers, a Delic Holdings subsidiary, abruptly shuts all of it22 Mar 2023 · Field Trip Health & Wellness: Field Trip Health & Wellness obtains CCAA creditor protection from the Ontario S5 Jul 2023 · Wesana Health: Wesana Health closes the sale of its SANA-013 assets, completing its exit from t16 Aug 2023 · Compass Pathways: Compass Pathways raises $285M in a private placement to fund the COMP360 phase 315 Sep 2023 · Neumora Therapeutics: Neumora completes a $250M IPO to fund late-stage navacaprant depression trials.26 Oct 2023 · Nue Life Health: Venture studio Beckley Waves acquires ketamine telehealth company Nue Life after22 Dec 2023 · Bristol Myers Squibb / Karuna Therapeutics: Bristol Myers Squibb agrees to acquire Karuna Therapeutics, adding KarXT ahead o4 Jan 2024 · atai Life Sciences / Beckley Psytech: atai makes a $50M strategic investment in Beckley Psytech, taking a minority sta5 Jan 2024 · Lykos Therapeutics (ex-MAPS PBC): MAPS PBC rebrands as Lykos Therapeutics and raises a $100M Series A ahead of its18 Mar 2024 · Cybin: Cybin closes an oversubscribed $150M private placement to fund CYB003 phase 3 anCYBIN: CYBIN CLOSES AN OVERSUBSCRIBED $150M PRIVATE PLACEMENT TO FUND CYB003 PHASE 3 AN13 Jun 2024 · Done Global: Done Global CEO Ruthia He and clinical president David Brody are arrested on fed12 Aug 2024 · Neuronetics / Greenbrook TMS: Neuronetics agrees an all-stock merger with Greenbrook TMS, the largest US TMS c13 Aug 2024 · MindMed: MindMed closes a $75M public offering, bringing 2024 gross equity raises to abou15 Aug 2024 · Lykos Therapeutics: Lykos cuts about 75% of its roughly 100 staff after the CRL and retractions; fou5 Sep 2024 · Lykos Therapeutics: Lykos CEO Amy Emerson steps down; COO Michael Mullette becomes interim CEO and D31 Oct 2024 · Compass Pathways: Compass delays COMP005 topline to Q2 2025 and COMP006 data to after the 26-week 15 Nov 2024 · Numinus Wellness / Stella: Numinus agrees to sell its five Utah wellness clinics to Stella MSO and pivots t9 Dec 2024 · Neuronetics / Greenbrook TMS: Neuronetics completes the Greenbrook TMS merger, becoming a vertically integrate17 Dec 2024 · Numinus Wellness / Stella: Numinus closes the sale of its US clinics to Stella and launches a data-sharing 10 Jan 2025 · Lykos Therapeutics / Antonio Gracias: Billionaire investor Antonio Gracias moves to take control of Lykos with about $13 Jan 2025 · Johnson & Johnson / Intra-Cellular Therapies: J&J agrees to acquire Intra-Cellular Therapies (Caplyta) in its largest neurosci15 Jan 2025 · Lykos Therapeutics: Five Lykos board directors depart as the company seeks new funding after the FDA22 Jan 2025 · Johnson & Johnson (Spravato): J&J Q4 2024 results show Spravato crossed $1B in annual sales for the first time30 May 2025 · Lykos Therapeutics: Lykos completes the first close of a Series B co-led by the Gracias Family Found2 Jun 2025 · atai Life Sciences / Beckley Psytech: atai agrees an all-share combination with Beckley Psytech, contingent on BPL-00316 Jun 2025 · Supernus Pharmaceuticals / Sage Therapeutics: Supernus agrees to acquire Sage Therapeutics (Zurzuvae) after Sage rebuffed Biog23 Jun 2025 · Compass Pathways: Compass shares fall sharply as investors judge the 3.6-point COMP005 effect size30 Jun 2025 · Cybin: Cybin announces a financing of up to $500M in convertible debentures to fund its20 Aug 2025 · Lykos Therapeutics: Lykos names former Point72 capital markets head Nick McEntire as president under28 Aug 2025 · Lykos Therapeutics / Resilient Pharmaceuticals: Lykos Therapeutics rebrands as Resilient Pharmaceuticals following the Gracias-l22 Oct 2025 · Mindbloom: A wrongful-death lawsuit is filed against at-home ketamine provider Mindbloom ov31 Oct 2025 · MindMed: MindMed closes an upsized underwritten public offering after positive phase 3 pl5 Nov 2025 · AtaiBeckley: atai and Beckley Psytech complete their combination to form AtaiBeckley; a $150M19 Nov 2025 · Done Global: A federal jury convicts Done founder Ruthia He and clinical president David Brod17 Dec 2025 · Done Global: A federal grand jury indicts Done Global itself over the alleged $100M Adderall 5 Jan 2026 · Cybin / Helus Pharma: Cybin rebrands as Helus Pharma and moves its US listing to Nasdaq under ticker H12 Jan 2026 · MindMed / Definium Therapeutics: MindMed rebrands as Definium Therapeutics (Nasdaq: DFTX from Jan 15) and guides 21 Jan 2026 · Johnson & Johnson (Spravato): J&J full-year 2025 results show Spravato sales of about $1.7B, with Q4 2025 up 618 Feb 2026 · Compass Pathways: Compass prices a $150M public offering the day after COMP006 topline; with warra1 Mar 2026 · Alto Neuroscience: Alto closes a $120M private placement led by Commodore Capital at $20 per share,17 Mar 2026 · Neuronetics: Neuronetics appoints Dan Reuvers as CEO as 2025 revenue nearly doubles after the7 Apr 2026 · Neuronetics: Neuronetics' top shareholder says the company has 'chronically underperformed' a29 Apr 2026 · GH Research: GH Research prices a $117.5M underwritten offering at $18 per share to fund the 13 May 2026 · Compass Pathways: Compass Q1 2026 update: rolling NDA sections already submitted, final submission25 Jun 2026 · Definium Therapeutics: Definium closes an upsized $805M public offering at $34 per share three days aft25 Jun 2026 · Helus Pharma: Helus completes a $50M underwritten offering, lifting cash to about $207M ahead 8 Jul 2026 · Done Global: Done founder Ruthia He is sentenced to 72 months in prison and fined $90M for th15 Jul 2026 · Johnson & Johnson (Spravato): J&J Q2 2026 results show Spravato sales of $584M, up 25% quarter over quarter an16 Jul 2026 · Eli Lilly / AtaiBeckley: Lilly agrees to acquire AtaiBeckley for $6.75 per share cash plus a CVR of up to3 Aug 2026 · Helus Pharma: Helus Pharma appoints Michael Halstead as chief executive officer ahead of its p11 Sep 2026 · Eli Lilly / AtaiBeckley: Eli Lilly completes its acquisition of AtaiBeckley, taking BPL-003 and VLS-01 inBETTERHELP OR TEL…BetterHelp or Teladoc Health ceases operations · stated 12 Mar 2023BetterHelp or Teladoc Health ceases operations · restated 12 Mar 2023 · p 50%BetterHelp or Teladoc Health ceases operations · miss 12 Mar 202550%TODAY202420252026

Company and market outcomes